Sameek Roychowdhury

Sameek Roychowdhury

UNVERIFIED PROFILE

Are you Sameek Roychowdhury?   Register this Author

Register author
Sameek Roychowdhury

Sameek Roychowdhury

Publications by authors named "Sameek Roychowdhury"

Are you Sameek Roychowdhury?   Register this Author

52Publications

1367Reads

19Profile Views

Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.

Fam Cancer 2020 Feb 12. Epub 2020 Feb 12.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, A440 Starling-Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-019-00152-6DOI Listing
February 2020

Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.

Methods Mol Biol 2020 ;2055:119-132

Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9773-2_5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010320PMC
January 2020

Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer.

Lung Cancer 2019 Aug 17;134:167-173. Epub 2019 Jun 17.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.017DOI Listing
August 2019

Implementing precision cancer medicine in the genomic era.

Semin Cancer Biol 2019 04 30;55:16-27. Epub 2018 May 30.

Department of Internal Medicine, Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2018.05.009DOI Listing
April 2019

Rapid Research Autopsy: Piecing the Puzzle of Tumor Heterogeneity.

Trends Cancer 2019 Jan 17;5(1):1-5. Epub 2018 Dec 17.

Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, OH, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2018.11.004DOI Listing
January 2019

Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.

Cold Spring Harb Mol Case Stud 2018 04 2;4(2). Epub 2018 Apr 2.

The Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880258PMC
April 2018

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

J Mol Diagn 2017 09 9;19(5):682-696. Epub 2017 Aug 9.

Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975628PMC
September 2017

Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.

Cell Rep 2016 12;17(10):2620-2631

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.11.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147555PMC
December 2016

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations.

J Vis Exp 2016 08 4(114). Epub 2016 Aug 4.

Department of Internal Medicine, Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University; Department of Pharmacology, The Ohio State University;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/54090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091715PMC
August 2016

Translating cancer genomes and transcriptomes for precision oncology.

CA Cancer J Clin 2016 Jan-Feb;66(1):75-88. Epub 2015 Nov 3.

Director, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713245PMC
May 2016

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.

J Natl Cancer Inst 2016 Apr 20;108(4). Epub 2015 Nov 20.

Departments of Internal Medicine (VMR) and Pathology (AMC), University of Michigan, Ann Arbor, MI; Dana-Farber Cancer Institute, Boston, MA (SWG); Harvard Medical School, Boston, MA (SWG); The Ohio State University, Columbus, OH (SR); University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (SJ); Texas Children's Cancer Center, Houston, TX (DWP, SEP); Baylor College of Medicine, Houston, TX (DWP, SEP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849259PMC
April 2016

Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.

Am Soc Clin Oncol Educ Book 2015 :e175-82

From the Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH; Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pharmacology, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557651PMC
February 2016

The Bayesian basket design for genomic variant-driven phase II trials.

Semin Oncol 2016 Feb 18;43(1):13-18. Epub 2016 Jan 18.

Department of Internal Medicine, The James Cancer Center, Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.01.002DOI Listing
February 2016

Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations.

J Mol Diagn 2015 Sep;17(5):554-9

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Department of Pharmacology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597274PMC
September 2015

Translating genomics for precision cancer medicine.

Annu Rev Genomics Hum Genet 2014 ;15:395-415

Department of Internal Medicine, Division of Medical Oncology, and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210; email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-genom-090413-025552DOI Listing
May 2015

Comparison of custom capture for targeted next-generation DNA sequencing.

J Mol Diagn 2015 Jan;17(1):64-75

Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio; Department of Pharmacology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279426PMC
January 2015

Advancing precision medicine for prostate cancer through genomics.

J Clin Oncol 2013 May 15;31(15):1866-73. Epub 2013 Apr 15.

University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 CCGC, Ann Arbor, MI 48109-5940, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.3662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808235PMC
May 2013

Implementing personalized cancer genomics in clinical trials.

Nat Rev Drug Discov 2013 May;12(5):358-69

Biometric Research Branch, US National Cancer Institute, Bethesda, Maryland 20892-7434, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd3979DOI Listing
May 2013

Cancer genomics meets clinical trials: the challenge ahead.

Per Med 2012 Jul;9(5):459-461

Department of Internal Medicine, Division of Hematology & Oncology, University of Michigan, Medical School, Ann Arbor, MI 48109, USA and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.12.50DOI Listing
July 2012

Managing resistance in chronic myeloid leukemia.

Blood Rev 2011 Nov 6;25(6):279-90. Epub 2011 Oct 6.

Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2011.09.001DOI Listing
November 2011

Cytokine therapy for cancer: antigen presentation.

Cancer Treat Res 2005 ;123:249-66

The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-387-27545-2_11DOI Listing
November 2005

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

Blood 2005 Oct 23;106(7):2433-5. Epub 2005 Jun 23.

Department of Molecular Virology, Immunology, and Medical Genetics, the Medical Scientist Program, the Integrated Biomedical Science Graduate Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-04-1597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895258PMC
October 2005

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.

Immunity 2005 Mar;22(3):295-304

Department of Molecular Virology, Immunology, and Medical Genetics, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2005.01.013DOI Listing
March 2005

IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.

Blood 2005 Feb 21;105(4):1558-65. Epub 2004 Oct 21.

Division of Surgical Oncology, Department of Surgery, Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-07-2476DOI Listing
February 2005

Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.

Blood 2005 Jan 16;105(2):894-901. Epub 2004 Sep 16.

Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-05-1687DOI Listing
January 2005

Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.

Cancer Res 2004 Nov;64(21):8062-7

Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1860DOI Listing
November 2004